Related Experiment Video
Updated: Jan 3, 2026

04:55
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
1.2K
Mechanical circulatory support in children: past, present and future
Svetlana B Shugh1, Kyle W Riggs2, David L S Morales2
1Heart Institute, Joe DiMaggio Children's Hospital, Hollywood, FL, USA.
Translational Pediatrics
|November 16, 2019
Summary
Mechanical circulatory support (MCS) and ventricular assist devices (VADs) have transformed pediatric heart failure care. Timely VAD implantation and improved management have reduced waitlist mortality and enabled chronic home therapy for children.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Surgery
- Biomedical Engineering
Background:
- Heart failure management in children has evolved significantly.
- Mechanical circulatory support (MCS) plays a crucial role in advanced pediatric heart failure.
- Ventricular assist devices (VADs) are increasingly utilized in pediatric care.
Purpose of the Study:
- To highlight the impact of recent advancements in MCS on pediatric heart failure management.
- To emphasize the importance of timely VAD implantation for end-organ function preservation.
- To discuss the evolving landscape of post-implant care and its effect on outcomes.
Main Methods:
- Review of current literature and clinical practices in pediatric MCS.
- Analysis of outcomes related to VAD implantation in pediatric patients.
- Examination of strategies for post-implant management, including stroke risk reduction.
Main Results:
- Significant decrease in transplant waitlist mortality attributed to VAD use.
- Successful off-label use of adult-approved devices in children.
- Improved end-organ function preservation and recovery post-VAD implantation.
- Establishment of chronic VAD therapy and home discharge as viable options.
Conclusions:
- Mechanical circulatory support, particularly VADs, has revolutionized pediatric heart failure treatment.
- Optimized timing of VAD implantation and enhanced post-implant care are critical for improving patient outcomes.
- The use of VADs offers a viable therapeutic option, reducing waitlist mortality and enabling long-term management outside the hospital.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
218
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
218
Cardiomyopathy II: Dilated Cardiomyopathy
412
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
412

